Literature DB >> 17068995

Designing a decision support system for existing clinical organizational structures: considerations from a rheumatology clinic.

Orjan Dahlström1, Ingrid Thyberg, Ursula Hass, Thomas Skogh, Toomas Timpka.   

Abstract

The aim of this study was to identify the social and organizational requirements for a decision support system (DSS) to be implemented in a clinical rheumatology setting, utilizing data-mining techniques. Field observations and focus group interviews were used for data collection. The decision-making was found to be situated, patient-focused, and long-term in nature. At the same time, the main part of peer-to-peer communication was informal. Patient records were involved in almost every decision. The conclusion is that the main challenges, when introducing a DSS at a rheumatology unit, are adapting the system to informal communication structures and integrating it with patient records. Considering incentive structures, understanding workflow and incorporating awareness are relevant issues when addressing these issues in future studies.

Entities:  

Mesh:

Year:  2006        PMID: 17068995     DOI: 10.1007/s10916-005-9000-1

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  27 in total

1.  The contextual nature of medical information.

Authors:  M Berg; E Goorman
Journal:  Int J Med Inform       Date:  1999-12       Impact factor: 4.046

2.  Paediatric clinical decision support systems.

Authors:  P Ramnarayan; J Britto
Journal:  Arch Dis Child       Date:  2002-11       Impact factor: 3.791

Review 3.  Incorporating ideas from computer-supported cooperative work.

Authors:  Wanda Pratt; Madhu C Reddy; David W McDonald; Peter Tarczy-Hornoch; John H Gennari
Journal:  J Biomed Inform       Date:  2004-04       Impact factor: 6.317

4.  Joint disorders and walking disability in Sweden by the year 2000. Epidemiologic studies of a Swedish community.

Authors:  S E Larsson; B Jónsson; L Palmefors
Journal:  Acta Orthop Scand Suppl       Date:  1991

5.  The prevalence of rheumatoid arthritis in Sweden.

Authors:  M Simonsson; S Bergman; L T Jacobsson; I F Petersson; B Svensson
Journal:  Scand J Rheumatol       Date:  1999       Impact factor: 3.641

Review 6.  Therapeutic strategies in early rheumatoid arthritis.

Authors:  Josef S Smolen; Daniel Aletaha; Klaus P Machold
Journal:  Best Pract Res Clin Rheumatol       Date:  2005-02       Impact factor: 4.098

7.  Aetiological factors of importance for the development of rheumatoid arthritis.

Authors:  A Reckner Olsson; T Skogh; G Wingren
Journal:  Scand J Rheumatol       Date:  2004       Impact factor: 3.641

Review 8.  New modes of practice.

Authors:  John R Kirwan
Journal:  Curr Opin Rheumatol       Date:  2004-03       Impact factor: 5.006

9.  Survey of the use and effect of assistive devices in patients with early rheumatoid arthritis: a two-year followup of women and men.

Authors:  Ingrid Thyberg; Ursula A M Hass; Ulla Nordenskiöld; Thomas Skogh
Journal:  Arthritis Rheum       Date:  2004-06-15

10.  CSCW-based system development methodology for health-care information systems.

Authors:  Gamini Weerakkody; Pradeep Ray
Journal:  Telemed J E Health       Date:  2003       Impact factor: 3.536

View more
  3 in total

Review 1.  Mobile clinical decision support systems and applications: a literature and commercial review.

Authors:  Borja Martínez-Pérez; Isabel de la Torre-Díez; Miguel López-Coronado; Beatriz Sainz-de-Abajo; Montserrat Robles; Juan Miguel García-Gómez
Journal:  J Med Syst       Date:  2014-01-08       Impact factor: 4.460

2.  Potential of the HAQ score as clinical indicator suggesting comprehensive multidisciplinary assessments: the Swedish TIRA cohort 8 years after diagnosis of RA.

Authors:  Ingrid Thyberg; Ö Dahlström; M Björk; P Arvidsson; M Thyberg
Journal:  Clin Rheumatol       Date:  2012-01-17       Impact factor: 2.980

Review 3.  [Artificial intelligence-supported treatment in rheumatology : Principles, current situation and perspectives].

Authors:  Thomas Hügle; Maria Kalweit
Journal:  Z Rheumatol       Date:  2021-10-07       Impact factor: 1.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.